Page 16 - Layout 1
P. 16

DIABETES AND
                    OBESITY




        DIABETES & OBESITY:




        How are they related and how we can prevent them.


        By Sherryl D. Mitchell Hernandez, MD

        A       ll of us love food. We love how it tastes and how it makes

                us feel after we eat! Plus, we live in a city with a great culi-
                nary background. but we must take into consideration
        that if we do not take the necessary measures to either control the
        amount and what we eat, we will be at a great risk of obesity and,
        therefore, diabetes.
          Most patients with type 2 diabetes are obese and there has been
        a dramatic increase in the incidence and prevalence of type 2 dia-
        betes over the past 20 years. Currently, over a third (34 percent) of
        U.S. adults are obese (defined as bMI >30 kg/m2), and over 11 per-
        cent of people aged ≥20 years have diabetes.
          Excess weight is an established risk factor for type 2 diabetes. Re-
        cent studies have identified “links” between obesity and type 2 dia-
        betes involving proinflammatory cells, insulin resistance, deranged
        fatty acid metabolism, and cellular processes such as mitochondrial
        dysfunction, which is where our energy is produced. The influence
        of obesity on type 2 diabetes risk is determined not only by the de-
        gree of obesity but also by where fat accumulates. Increased upper
        body fat includes visceral adiposity, as reflected in increased abdom-
        inal girth or waist-to-hip ratio, which is associated with the metabolic
        syndrome, type 2 diabetes, and cardiovascular disease. The link be-
        tween obesity and hyperinsulinemia, first identified about 50 years
        ago, reflects compensation by insulin-secreting β-cells to systemic
        insulin resistance. Although mechanisms underlying this coupling
        (e.g., mild hyperglycemia and raised levels of circulating free fatty
        acids) remain elusive, obese normoglycemic individuals have both
        increased β-cell mass and function. Obesity-induced glucose intol-
        erance reflects failure to mount one or more of these compensatory
        responses. The Genome-wide association scans (GWAS) and can-
        didate gene approaches now have identified ∼40 genes associated
        with type 2 diabetes and a similar number, albeit largely different,
        with obesity. Most type 2 diabetes genes appear to be related to β-
        cell dysfunction, with many fewer involved in pathways related to
        insulin resistance independent of obesity. Although numerous dia-
        betes- and obesity-associated genes have been identified, the known


         16  San Antonio Medicine   •  December  2018
   11   12   13   14   15   16   17   18   19   20   21